Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) agreed to acquire a 38.39992% stake in Tianjin Guohui Big Health Technology Co., Ltd. from Yantai Huishuo Enterprise Management Partnership Enterprise for approximately CNY 230 million on February 17, 2022. Under the terms, Within 3 days after the agreement becomes effective, the Realcan Pharmaceutical will pay 50% of the transfer price. After the completion of the transfer, the Realcan Pharmaceutical will pay 50% of the transfer price within 10 days after the agreement becomes effective.

Transaction has been approved at 19th Meeting of the the Realcan Pharmaceutical's 4th Directorate held on February 17, 2022, and does not need the Shareholders' Approval. For the period ended October 31, 2021, Tianjin Guohui had CNY 98.58 million of Total Assets and CNY 341.65 million and Net Assets.